Hall C
Sala Napoleonica

Pre-Conference Workshop 1
Older therapies for depression: practical guidance on indications and use - MAOIs, Lithium, Thyroid Hormone, Tricyclics, Tryptophan & Classic Combinations

Allan Young (King's College London, UK), Philipp Ritter (University Hospital Carl Gustav Carus, Germany), Anthony Cleare (King's College London, UK), Eric Ruhe (Radboud University, Netherlands)

BREAK

Pre-Conference Workshop 2
Psychedelic therapy, what it is & how to do it

Catherine Bird (King's College London, UK), Carolina Maggio (King's College London, UK), Liam Nadav Modlin (King's College London, UK) and James Rucker (King's College London, UK)

BREAK

Conference Opening Ceremony
Anthony Cleare, King's College London, UK, ISAD President

In Memoriam Prof. Eugene Paykel (1934-2023), ISAD Founder Fellow
Allan Young, King's College London, UK, ISAD Past President

Presidential Opening Plenary Session
Chair: Anthony Cleare, King's College London, UK

Imaging and immunogenic features of affective (and non affective) psychosis
Paolo Brambilla, University of Milan, Italy

The finger of blame, depression and the brain
Roland Zahn, King's College London, UK

Plenary Symposium 1
IGSLI Faculty Symposium: Quo Vadis LithiumTherapy?

Chair: Janusz Rybakowski, Poznan University of Medical Sciences, Poland

Genomic and neurobiological studies can elucidate the mode of action of lithium
Martin Alda, Dalhousie University, Canada

Lithium in the treatment of depression and suicide prevention
Michael Bauer, Technical University of Dresden, Germany

Adverse side effects of lithium: are they manageable?
Ursula Werneke, Umeå University, Sweden

For broader use of lithium: Correcting the anomalous association between lithium data and lithium use
Janusz Rybakowski, Poznan University of Medical Sciences, Poland

Commentary: Patient and Public Involvement and Engagement
Chair: Allan Young, King's College London, UK

Patient perspectives on Lithium
Marylou Selo, Patient Advocate, USA

Welcome Reception